These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 32956113)

  • 1. Re: Medical Event: Accidental Oral Administration of 177Lu-PSMA to a Patient With Hyperthyroidism.
    Rahbar K; Ahmadzadehfar H
    Clin Nucl Med; 2021 Oct; 46(10):856. PubMed ID: 32956113
    [No Abstract]   [Full Text] [Related]  

  • 2. Medical Event: Accidental Oral Administration of 177Lu-PSMA to a Patient With Hyperthyroidism.
    Zarehparvar Moghadam S; Aghaee A; Esmatinia M; Nateghi N; Aryana K
    Clin Nucl Med; 2020 Jun; 45(6):439-441. PubMed ID: 32349091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 177Lu-PSMA Therapy for Metastatic Castration-Resistant Prostate Cancer: A Mini-Review of State-of-the-Art.
    AlSadi R; Bouhali O; Dewji S; Djekidel M
    Oncologist; 2022 Dec; 27(12):e957-e966. PubMed ID: 36288537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcome of 177Lu-PSMA-617 radioligand therapy in heavily pre-treated metastatic castration-resistant prostate cancer patients.
    Yadav MP; Ballal S; Sahoo RK; Tripathi M; Damle NA; Shamim SA; Kumar R; Seth A; Bal C
    PLoS One; 2021; 16(5):e0251375. PubMed ID: 33970962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The oral use of para-amino benzoic acid sodium for hyperthyroidism.
    POPP A
    Marquette Med Rev; 1947 Nov; 13(1):23-6. PubMed ID: 20272666
    [No Abstract]   [Full Text] [Related]  

  • 6. Response to RL-225Ac in prostate cancer: Effect of prior treatment with RL-177Lu: A systematic review of the literature.
    Stangl-Kremser J; Ricaurte-Fajardo A; Subramanian K; Osborne JR; Sun M; Tagawa ST; Bander NH
    Prostate; 2023 Jul; 83(10):901-911. PubMed ID: 36960580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-Effectiveness Analysis of 177Lu-PSMA-617 Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer.
    Mehrens D; Kramer KKM; Unterrainer LM; Beyer L; Bartenstein P; Froelich MF; Tollens F; Ricke J; Rübenthaler J; Schmidt-Hegemann NS; Herlemann A; Unterrainer M; Kunz WG
    J Natl Compr Canc Netw; 2023 Jan; 21(1):43-50.e2. PubMed ID: 36634610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Intravenous or oral 131I treatment of hyperthyroidism and thyroid cancer?].
    Müller KD; Grebe SF; Bock FL; Müller H; Fängewisch GL
    Nuklearmedizin; 1994 Jun; 33(3):87-92. PubMed ID: 8090631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma C-peptide response to oral glucose load in hyperthyroidism.
    Bonora E; Manicardi V; Zenere M; Moghetti P; Coscelli C; Muggeo M
    J Endocrinol Invest; 1990; 13(7):555-8. PubMed ID: 2229928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of hyperthyroidism in a patient with idiopathic nephrotic syndrome.
    Kubota T; Hirai H; Shimizu N; Sawada A; Kondou H; Nakajima S; Harada T; Shima M
    Pediatr Nephrol; 2002 May; 17(5):367-9. PubMed ID: 12042896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Variables Associated with PSA Response to Lutetium-177-PSMA ([177Lu]-PSMA-617) Radionuclide Treatment in Men with Metastatic Castration-Resistant Prostate Cancer.
    Gadot M; Davidson T; Aharon M; Atenafu EG; Malki A; Levartovsky M; Saad A; Domachevsky L; Berger R; Leibowitz R
    Cancers (Basel); 2020 Apr; 12(5):. PubMed ID: 32357427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate-Specific Membrane Antigen (PSMA)-Targeted Radionuclide Therapies for Prostate Cancer.
    Sun M; Niaz MJ; Niaz MO; Tagawa ST
    Curr Oncol Rep; 2021 Mar; 23(5):59. PubMed ID: 33778927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperthyroidism and diabetes mellitus. An analysis of 70 patients.
    Cooppan R; Kozak GP
    Arch Intern Med; 1980 Mar; 140(3):370-3. PubMed ID: 6767456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of oral cholecystographic agents in the treatment of amiodarone-induced hyperthyroidism.
    Chopra IJ; Baber K
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4707-10. PubMed ID: 11600529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adrenergic beta blockaders in hyperthyroidism (adrenergic beta block with propranolol as the sole preparatory treatment of hyperthyroidism in parital thyroidectomy].
    Ramírez Del Villar E; Wurst Zevallos G; Bouroncle Carreón M; Uribe LJ
    Rev Neuropsiquiatr; 1973 Jun; 36(2):107-16. PubMed ID: 4793306
    [No Abstract]   [Full Text] [Related]  

  • 16. Basal TSH levels compared with TRH-stimulated TSH levels to diagnose different degrees of TSH suppression: diagnostic and therapeutic impact of assay performance.
    Christ-Crain M; Meier C; Roth CB; Huber P; Staub JJ; Müller B
    Eur J Clin Invest; 2002 Dec; 32(12):931-7. PubMed ID: 12534453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacokinetics of digoxin in hyperthyroidism. Effect of methimazole].
    Izbicka M; Gasińska T; Dec R
    Wiad Lek; 2010; 63(1):10-6. PubMed ID: 20701025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Costs of radium-223 and the pharmacy preparation
    Quist SW; Paulissen JHJ; Wyndaele DNJ; Nagarajah J; Freriks RD
    J Med Econ; 2023; 26(1):366-375. PubMed ID: 36905581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of methimazole in normal cats and cats with hyperthyroidism.
    Trepanier LA; Peterson ME; Aucoin DP
    Res Vet Sci; 1991 Jan; 50(1):69-74. PubMed ID: 2047595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of oral cholecystography agents in the treatment of hyperthyroidism of subacute thyroiditis.
    Martinez DS; Chopra IJ
    Panminerva Med; 2003 Mar; 45(1):53-7. PubMed ID: 12682620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.